Increased protein expression of p16 and cyclin D1 in squamous cell carcinoma tissues

BioScience Trends

Volumn 3, Issue 3, 2009, Pages 105-109

  Eshkoor, Sima Ataollahi ^a   Ismail, Patimah ^a   Rahman, Sabariah Abdul ^a   Mirinargesi, Mirsaed ^a   Oshkour, Soraya Ataollahi ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Shafa st Hasan Makiabadi Clinic   (Iran)

Author keywords

Cyclin D1; P16; Retinoblastoma pathway; Squmous cell carcinoma; Tissue microarray

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CELL CYCLE; HUMAN; KOREA; METABOLISM; METHODOLOGY; PHYSIOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYCLIN D1; HUMANS; KOREA; NEOPLASM PROTEINS; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 77952554672     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Andhu C, Slingerland J. Deregulation of the cell cycle in cancer. Cancer Detect Prev. 2000; 24:107-118.
2. Boukamp P. UV induced skin cancer: similaritiesvariations. J Dtsch Dermato Ges. 2005; 3:493-503.
3. Utikal J, Udart M, Leiter U, Kaskel P, Peter RU, Krahn G. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer. Cancer Lett. 2005; 219:197-204.
4. Scheinfeld NS. 2006. Skin Malignancies, Squamous Cell Carcinoma.
5. Spickler AR. 2006. Squamous Cell Carcinoma of the Skin.
6. Claerhout S, Van Laethem A, Agostinis P, Garmyn M. Pathways involved in sunburn cell formation: deregulation in skin cancer. Photochem Photobiol Sci. 2006; 5:199-207.
7. Burnworth B, Arendt S, Muffler S, Steinkraus V, Brocker EB, Birek C, Hartschuh W, Jauch A, Boukamp P. The multi-step process of human skin carcinogenesis: A role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol. 2007; 86:763-780.
8. Bosserhoff AK. Novel biomarkers in malignant melanoma. Clinica Chimica Acta. 2006; 367:28-35.
9. Sompuram SR, Kodela V, Zhang K, Ramanathan H, Radcliffe G, Falb P, Bogen SA. A novel quality control slide for quantitative immunohistochemistry testing. J Histochem Cytochem. 2002; 50:1425-1433.
10. Sanno N, Jin L, Qian X, Osamura RY, Scheithauer BW, Kovacs K, Lloyd RV. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries. J Clin Endocrinol Metab. 1997; 82:1974-1982.
11. Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res. 2001; 7:3862-3868.
12. Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005; 4:32.
13. Lu Q, Lu F, Yang Z, Wen H, Yan L, Chen S, Liu BA. Study on regulators of the cell cycle in cutaneous squamous cell carcinoma. Hunan Yi Ke Da Xue Xue Bao. 1999; 24:438-440.
14. Kim AL, Athar M, Bickers DR, Gautier J. Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. J Photochem Photobiol. 2002; 75:58-67.
15. Watanabe A, Cornelison R, Hostetter G. Tissue microarrays: Applications in genomic research. Expert Rev Mol Diagn. 2005; 5:171-181.
16. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer. 1996; 74:1847-1850.
17. Yamamoto H. Enhanced skin carcinogenesis in cyclin D1 conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation. Cancer Res. 2002; 62:1641-1647.
18. Bianchi AB, Fischer SM, Robles AI, Rinchik EM, Conti CJ. Over expression of cyclin D1 in mouse skin carcinogenesis. Oncogene. 1993; 8:1127-1133.
19. Burnworth B, Popp S, Stark HJ, Steinkraus V, Brocker EB, Hartschuh W, Birek C, Boukamp P. Gain of 11q/ cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene. 2006; 25:4399-4412.
20. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJP, Cheffetz S, Herlyn M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res. 1999; 59:4876-4881.
21. Nindl I, Meyer T, Schmook T, Stockfleth E. Human Papillomavirus and overexpression of p16INK4a in nonmelanom skin cancer. Dermatol Surg. 2004; 30:409-414.
22. Nakamura S. Enhanced expression of p16 in seborrhoeic keratosis; a lesion of accumulated senescent epidermal cells in G1 arrest. Br J Dermatol. 2003; 149:560-565.
23. Nilsson K. Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod Pathol. 2004; 17:1464-1474.
24. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H, Ingvar C. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutationpositive melanoma families. J Natl Cancer Inst. 2000; 2:1260-1266.
25. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res. 1995; 15:5168-5172.